RWD DSC-800 Automated Single-Cell Suspension Preparation System

Overview

The RWD DSC-800 Automated Single-Cell Suspension Preparation System is an engineered platform designed for reproducible, gentle, and standardized dissociation of fresh or preserved tissue specimens into high-viability single-cell suspensions or homogenates. It operates on a controlled mechanical–enzymatic principle: integrated precision motor-driven agitation (0–4000 rpm), programmable thermal regulation (0–56 °C), and validated enzymatic digestion protocols act in concert to minimize shear stress while maximizing cell membrane integrity and surface epitope preservation. Unlike manual or semi-automated methods prone to operator variability, the DSC-800 delivers consistent dissociation kinetics across replicates—critical for applications demanding high biological fidelity, such as single-cell RNA sequencing (scRNA-seq), primary cell isolation, flow cytometry, FACS sorting, and autologous cell therapy manufacturing. Its eight independent processing channels enable parallel, non-cross-contaminating sample handling, supporting both experimental scalability and inter-sample comparability under GLP-aligned operational conditions.

Key Features

• Fully automated, eight-channel architecture with individual motor control and thermal management per channel—enabling simultaneous processing of heterogeneous tissue types without cross-talk.
• Integrated heating jacket system maintaining precise temperature setpoints from 0 °C (for cold-sensitive neural tissues) to 56 °C (for accelerated enzymatic activity), with ±0.5 °C stability over time.
• 7-inch capacitive touchscreen interface supporting intuitive workflow navigation, real-time process monitoring, and audit-trail-enabled parameter logging.
• Programmable rotor speed control (0–4000 rpm) with adaptive torque compensation—ensuring stable agitation across viscosity gradients during progressive tissue breakdown.
• Sealed, sterile, single-use tissue processing tubes (SCT-25/SCT-100) certified for ISO 13485-compliant aseptic handling; pre-sterilized, individually wrapped, and compatible with standard biosafety cabinets.
• Multi-layer safety architecture including lid-in-place detection, vibration anomaly recognition, thermal runaway prevention, and automatic emergency shutdown upon deviation from preset thresholds.

Sample Compatibility & Compliance

The DSC-800 accommodates a broad spectrum of mammalian tissues—including murine tumor, adult and neonatal brain, human solid tumors, intestinal mucosa, adipose depots, and glioblastoma specimens—when paired with RWD’s ISO 13485-manufactured enzyme kits (e.g., DHTE-5001, DHNBE-5002, DHABE-5003). Each kit contains optimized protease/collagenase blends validated for minimal CD marker degradation and maximal live-cell yield (>85% viability by trypan blue exclusion). The system supports buffer volumes from 0.3–10 mL and tissue masses from 20–4000 mg per tube. All consumables comply with EU Directive 2017/746 (IVDR) classification requirements for in vitro diagnostic ancillary reagents. While the instrument itself is not FDA-cleared, its design aligns with principles outlined in FDA Guidance for Industry: “Considerations for the Design, Development, and Manufacture of Cell-Based Products” (2022) and supports 21 CFR Part 11–compliant data integrity when integrated with validated LIMS environments.

Software & Data Management

The embedded firmware enables USB-based protocol import/export, version-controlled method storage (up to 100 user-defined programs), and timestamped execution logs—including rpm, temperature, duration, and error flags. Firmware updates are delivered via encrypted firmware packages with SHA-256 verification. When deployed in multi-unit laboratories, synchronized operation across instruments is achievable through shared network-mounted configuration directories, facilitating harmonized SOP deployment across core facilities. Audit trails meet ALCOA+ criteria (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) for GLP and GMP-aligned workflows.

Applications

• Preparation of high-integrity single-cell suspensions for scRNA-seq library construction and spatial transcriptomics integration.
• Isolation of viable primary neurons, microglia, TILs, and stromal cells for functional assays and expansion cultures.
• Generation of standardized input material for spectral flow cytometry and high-parameter immunophenotyping.
• Scalable production of clinical-grade cell products under cGMP-compatible process definitions.
• Routine tissue homogenization for protein extraction, metabolite profiling, or nucleic acid purification where cellular lysis must be avoided.

FAQ

Is the DSC-800 compliant with FDA 21 CFR Part 11 for electronic records?
The device generates audit-ready logs and supports external validation of software controls; full Part 11 compliance requires site-specific validation protocols and integration with a qualified electronic signature system.
Can the system process cryopreserved tissues?
Yes—validated protocols exist for thawed frozen tissues; optimal results require pre-thaw equilibration at 4 °C and use of low-temperature enzyme kits (e.g., DHNBE-5002).
Are tissue processing tubes available in the United States?
No—SCT-series tubes are currently distributed only in APAC and EMEA regions per regional regulatory pathways.
What maintenance is required for long-term reliability?
Biannual calibration of temperature sensors and annual motor bearing inspection are recommended; no routine lubrication or consumable wear parts are required beyond disposable tubes and enzyme kits.
Does the system support remote monitoring or integration with lab automation systems?
Native Ethernet connectivity enables SNMP-based status polling; custom API integration (REST/JSON) is available under NDA for enterprise LIMS or robotic workflow orchestration.